BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Fournier Pharma 

42, rue de Longvic

Chenove    21300  France
Phone: 33-0-3-80-44-70-00 Fax: 33-0-3-80-44-73-10


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Lupin Ltd. (LUPN.BO) Inks Pact with Abbott Laboratories (ABT), Fournier Pharma 4/6/2011 11:27:14 AM
TEMIS Text Analytics Solution to Support Fournier Pharma's Drug Discovery Process 11/30/2007 12:57:52 PM
Solvay SA To Buy France's Fournier Pharma For 1.6 Billion Euros ($2.09 billion)10/19/2005 5:13:06 PM
Fournier Pharma Has Been Granted Orphan Drug Designation By The European Commission (EC) For ANATIBANT For The Treatment Of Moderate And Severe Traumatic Brain Injury10/19/2005 5:10:39 PM
Multi-Year Drug Discovery Agreement Between Fournier Pharma And ComGenex Inc.10/19/2005 5:10:03 PM
Fournier Pharma Announces The Receipt Of U.S. FDA Orphan Drug Status For Anatibant For Treatment Of Severe Traumatic Brain Injury10/19/2005 5:09:45 PM
Biofield Corp. (BZET) Signs Preliminary Letter Of Understanding For Potential Merger With BPG, LLC, A Developer Of The Fournier Pharma Feminine Multi-Test10/19/2005 5:09:24 PM
Fournier Pharma And Xytis Pharmaceuticals Ltd. Announces Agreement For Development And Commercialisation Of Anatibant10/19/2005 5:08:55 PM